| - GRCh37:
- Chr16:70310388
- GRCh38:
- Chr16:70276485
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr16:70293060
- GRCh38:
- Chr16:70259157
| AARS1 | H605Q | Charcot-Marie-Tooth disease axonal type 2N | Likely pathogenic (Jun 2, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70301697
- GRCh38:
- Chr16:70267794
| AARS1 | E363Q | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (May 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70302268
- GRCh38:
- Chr16:70268365
| AARS1 | R326P | Charcot-Marie-Tooth disease axonal type 2N | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70289725
- GRCh38:
- Chr16:70255822
| AARS1 | S731W | Charcot-Marie-Tooth disease axonal type 2N | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70310890
- GRCh38:
- Chr16:70276987
| AARS1 | W104* | Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N | Conflicting interpretations of pathogenicity (Nov 3, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70301691
- GRCh38:
- Chr16:70267788
| AARS1 | K365E | Charcot-Marie-Tooth disease type 2 | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70301604
- GRCh38:
- Chr16:70267701
| AARS1 | D394Y | Charcot-Marie-Tooth disease type 2 | Uncertain significance (Jun 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70292997
- GRCh38:
- Chr16:70259094
| AARS1 | | Charcot-Marie-Tooth disease type 2 | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70296406
- GRCh38:
- Chr16:70262503
| AARS1 | T505M | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Jan 9, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70302236
- GRCh38:
- Chr16:70268333
| AARS1 | E337K | Charcot-Marie-Tooth disease type 2 | Pathogenic (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70292906
- GRCh38:
- Chr16:70259003
| AARS1 | N657D | Charcot-Marie-Tooth disease type 2, Trichothiodystrophy 8, nonphotosensitive, Charcot-Marie-Tooth disease axonal type 2N, Developmental and epileptic encephalopathy, 29, Leukoencephalopathy, hereditary diffuse, with spheroids 2 | Uncertain significance (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70298909
- GRCh38:
- Chr16:70265006
| AARS1 | D482Y | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Jun 28, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70301613
- GRCh38:
- Chr16:70267710
| AARS1 | R391C | Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N | Conflicting interpretations of pathogenicity (Oct 26, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70289632
- GRCh38:
- Chr16:70255729
| AARS1 | K762R | Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2 | Uncertain significance (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70303655
- GRCh38:
- Chr16:70269752
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70303537
- GRCh38:
- Chr16:70269634
| AARS1 | D316Y | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Apr 28, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70292094
- GRCh38:
- Chr16:70258191
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70292000
- GRCh38:
- Chr16:70258097
| AARS1 | E705K | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Apr 28, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70302186
- GRCh38:
- Chr16:70268283
| AARS1 | | Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N | Conflicting interpretations of pathogenicity (Aug 22, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70301674
- GRCh38:
- Chr16:70267771
| AARS1 | M370I | Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (May 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70298978
- GRCh38:
- Chr16:70265075
| AARS1 | G459R | Inborn genetic diseases, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N
| Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70286592
- GRCh38:
- Chr16:70252689
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70286493
- GRCh38:
- Chr16:70252590
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70286483
- GRCh38:
- Chr16:70252580
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70305854
- GRCh38:
- Chr16:70271951
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70296287
- GRCh38:
- Chr16:70262384
| AARS1 | E545K | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70296264
- GRCh38:
- Chr16:70262361
| AARS1 | | Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N | Benign/Likely benign (Aug 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70302202
- GRCh38:
- Chr16:70268299
| AARS1 | T348M | Charcot-Marie-Tooth disease axonal type 2N, Inborn genetic diseases, Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2 | Uncertain significance (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70286801
- GRCh38:
- Chr16:70252898
| AARS1 | | Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N | Likely benign (Sep 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70287632
- GRCh38:
- Chr16:70253729
| AARS1 | | Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N | Benign/Likely benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70310438
- GRCh38:
- Chr16:70276535
| AARS1 | A144T | Inborn genetic diseases, not provided, Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2 | Conflicting interpretations of pathogenicity (Oct 11, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70305737
- GRCh38:
- Chr16:70271834
| AARS1 | Q206H | Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N | Conflicting interpretations of pathogenicity (Oct 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70310526
- GRCh38:
- Chr16:70276623
| AARS1 | | not provided, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N
| Conflicting interpretations of pathogenicity (Oct 14, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:63398659
- GRCh38:
- Chr11:63631187
| ATL3 | I446M, I464M | Neuropathy, hereditary sensory, type 1F | Uncertain significance (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70293052
- GRCh38:
- Chr16:70259149
| AARS1 | T608M | Charcot-Marie-Tooth disease, not provided, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N | Conflicting interpretations of pathogenicity (Oct 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70294970
- GRCh38:
- Chr16:70261067
| AARS1 | Q588* | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Nov 30, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70302269
- GRCh38:
- Chr16:70268366
| AARS1 | R326W | Charcot-Marie-Tooth disease type 2, Inborn genetic diseases, not provided, Peripheral neuropathy | Conflicting interpretations of pathogenicity (Nov 17, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70310990
- GRCh38:
- Chr16:70277087
| AARS1 | N71S | Inborn genetic diseases, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N, not provided | Uncertain significance (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70310874
- GRCh38:
- Chr16:70276971
| AARS1 | F110L | Charcot-Marie-Tooth disease axonal type 2N | Likely pathogenic (Apr 25, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr16:70296411
- GRCh38:
- Chr16:70262508
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2 | Benign/Likely benign (Oct 24, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70287952
- GRCh38:
- Chr16:70254049
| AARS1 | | not specified, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N
| Conflicting interpretations of pathogenicity (Jul 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70303524
- GRCh38:
- Chr16:70269621
| AARS1 | R320H | Charcot-Marie-Tooth disease axonal type 2N, Leukoencephalopathy, hereditary diffuse, with spheroids 2, Trichothiodystrophy 8, nonphotosensitive, Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease type 2, Inborn genetic diseases
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70316604
- GRCh38:
- Chr16:70282701
| AARS1 | | Inborn genetic diseases, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N
| Conflicting interpretations of pathogenicity (Oct 20, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70310943
- GRCh38:
- Chr16:70277040
| AARS1 | D87N | not provided, Charcot-Marie-Tooth disease type 2 | Uncertain significance (Aug 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70316697-70316698
- GRCh38:
- Chr16:70282794-70282795
| AARS1 | | not specified, Charcot-Marie-Tooth disease axonal type 2N, Developmental and epileptic encephalopathy, 29, Trichothiodystrophy 8, nonphotosensitive, Leukoencephalopathy, hereditary diffuse, with spheroids 2 | Likely benign (Oct 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70302226
- GRCh38:
- Chr16:70268323
| AARS1 | N340S | not provided, Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease, Inborn genetic diseases, Charcot-Marie-Tooth disease type 2 | Conflicting interpretations of pathogenicity (Oct 11, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70296239
- GRCh38:
- Chr16:70262336
| AARS1 | | Charcot-Marie-Tooth disease type 2, not provided, Charcot-Marie-Tooth disease axonal type 2N
| Likely benign (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70298925
- GRCh38:
- Chr16:70265022
| AARS1 | | Inborn genetic diseases, not provided, Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2 | Benign/Likely benign (Dec 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70289753
- GRCh38:
- Chr16:70255850
| AARS1 | | Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N, not specified
| Likely benign (Oct 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70323410
- GRCh38:
- Chr16:70289507
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70316603
- GRCh38:
- Chr16:70282700
| AARS1 | E22K | Charcot-Marie-Tooth disease type 2, not provided, Charcot-Marie-Tooth disease axonal type 2N
| Benign/Likely benign (Oct 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70316576
- GRCh38:
- Chr16:70282673
| AARS1 | T31A | Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2 | Uncertain significance (Nov 11, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70310866
- GRCh38:
- Chr16:70276963
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2, Inborn genetic diseases
| Conflicting interpretations of pathogenicity (Oct 12, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70305883
- GRCh38:
- Chr16:70271980
| AARS1 | | not provided, Charcot-Marie-Tooth disease axonal type 2N | Conflicting interpretations of pathogenicity (Nov 1, 2019) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70305794
- GRCh38:
- Chr16:70271891
| AARS1 | | Inborn genetic diseases, Charcot-Marie-Tooth disease type 2, not provided, not specified, Charcot-Marie-Tooth disease axonal type 2N | Benign/Likely benign (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70305681
- GRCh38:
- Chr16:70271778
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2, not provided
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70304174
- GRCh38:
- Chr16:70270271
| AARS1 | | Inborn genetic diseases, not provided, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N | Benign/Likely benign (Oct 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70304109
- GRCh38:
- Chr16:70270206
| AARS1 | A269G | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70303659
- GRCh38:
- Chr16:70269756
| AARS1 | G275D | Charcot-Marie-Tooth disease axonal type 2N, not provided, Charcot-Marie-Tooth disease type 2
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70303579
- GRCh38:
- Chr16:70269676
| AARS1 | A302T | not provided, Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2 | Conflicting interpretations of pathogenicity (Oct 31, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70303506
- GRCh38:
- Chr16:70269603
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2 | Conflicting interpretations of pathogenicity (Jun 8, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70301664
- GRCh38:
- Chr16:70267761
| AARS1 | I374V | Charcot-Marie-Tooth disease type 2, not provided, Charcot-Marie-Tooth disease axonal type 2N
| Uncertain significance (Oct 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70299535
- GRCh38:
- Chr16:70265632
| AARS1 | Y418C | Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2, Inborn genetic diseases, Charcot-Marie-Tooth disease | Conflicting interpretations of pathogenicity (Nov 1, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70299456
- GRCh38:
- Chr16:70265553
| AARS1 | | Charcot-Marie-Tooth disease type 2, not specified, not provided, Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2N | Benign/Likely benign (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70298943
- GRCh38:
- Chr16:70265040
| AARS1 | | not provided, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N, Inborn genetic diseases | Benign/Likely benign (Nov 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70296434
- GRCh38:
- Chr16:70262531
| AARS1 | | Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N | Conflicting interpretations of pathogenicity (Aug 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70296333
- GRCh38:
- Chr16:70262430
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N, Inborn genetic diseases | Conflicting interpretations of pathogenicity (Jul 11, 2019) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70296324
- GRCh38:
- Chr16:70262421
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N, Inborn genetic diseases | Conflicting interpretations of pathogenicity (Jul 11, 2019) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70296309
- GRCh38:
- Chr16:70262406
| AARS1 | E537D | Charcot-Marie-Tooth disease axonal type 2N, Inborn genetic diseases | Uncertain significance (Mar 20, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70294995
- GRCh38:
- Chr16:70261092
| AARS1 | | not specified, not provided, Charcot-Marie-Tooth disease type 2, Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2N | Benign/Likely benign (Aug 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70293051
- GRCh38:
- Chr16:70259148
| AARS1 | | not specified, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N, Inborn genetic diseases | Likely benign (Sep 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70293029
- GRCh38:
- Chr16:70259126
| AARS1 | R616C | not provided, Inborn genetic diseases, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70292004
- GRCh38:
- Chr16:70258101
| AARS1 | | Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N, Inborn genetic diseases
| Conflicting interpretations of pathogenicity (Feb 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70291984
- GRCh38:
- Chr16:70258081
| AARS1 | P710L | not provided, Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2
| Uncertain significance (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70289700
- GRCh38:
- Chr16:70255797
| AARS1 | | Charcot-Marie-Tooth disease type 2, Inborn genetic diseases, not provided, Charcot-Marie-Tooth disease axonal type 2N | Likely benign (Sep 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70289677
- GRCh38:
- Chr16:70255774
| AARS1 | K747R | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70288546
- GRCh38:
- Chr16:70254643
| AARS1 | R793T | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70287921
- GRCh38:
- Chr16:70254018
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N, Inborn genetic diseases | Conflicting interpretations of pathogenicity (Jul 11, 2019) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70287644
- GRCh38:
- Chr16:70253741
| AARS1 | | Inborn genetic diseases, Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2, not provided, Charcot-Marie-Tooth disease axonal type 2N | Conflicting interpretations of pathogenicity (Jul 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70287628
- GRCh38:
- Chr16:70253725
| AARS1 | A866T | Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N, not provided
| Uncertain significance (Sep 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70287192
- GRCh38:
- Chr16:70253289
| AARS1 | | Inborn genetic diseases, Charcot-Marie-Tooth disease type 2, not provided, Charcot-Marie-Tooth disease axonal type 2N | Benign/Likely benign (Nov 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70287177
- GRCh38:
- Chr16:70253274
| AARS1 | | Charcot-Marie-Tooth disease type 2, Developmental and epileptic encephalopathy, 29, not provided, Charcot-Marie-Tooth disease axonal type 2N | Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70286799
- GRCh38:
- Chr16:70252896
| AARS1 | N911S | AARS1-related condition, Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2, Inborn genetic diseases, not provided, Charcot-Marie-Tooth disease axonal type 2N
| Conflicting interpretations of pathogenicity (Oct 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70286550
- GRCh38:
- Chr16:70252647
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N, not provided | Benign (Jun 16, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70286455
- GRCh38:
- Chr16:70252552
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70286411
- GRCh38:
- Chr16:70252508
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70286373
- GRCh38:
- Chr16:70252470
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N, not provided | Benign/Likely benign (Dec 23, 2018) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70286300
- GRCh38:
- Chr16:70252397
| AARS1 | | Charcot-Marie-Tooth disease axonal type 2N | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70303580
- GRCh38:
- Chr16:70269677
| AARS1 | | not specified, not provided, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N | Benign (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70302201
- GRCh38:
- Chr16:70268298
| AARS1 | | Inborn genetic diseases, Charcot-Marie-Tooth disease type 2, not specified, not provided, Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease axonal type 2N, Leukoencephalopathy, hereditary diffuse, with spheroids 2, Trichothiodystrophy 8, nonphotosensitive, Charcot-Marie-Tooth disease axonal type 2N
| Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70298872
- GRCh38:
- Chr16:70264969
| AARS1 | S494I | Charcot-Marie-Tooth disease type 2, not provided, Charcot-Marie-Tooth disease axonal type 2N
| Conflicting interpretations of pathogenicity (Oct 13, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70289731
- GRCh38:
- Chr16:70255828
| AARS1 | R729Q | Inborn genetic diseases, Charcot-Marie-Tooth disease type 2, Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease axonal type 2N, not provided | Conflicting interpretations of pathogenicity (Oct 26, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70305837
- GRCh38:
- Chr16:70271934
| AARS1 | D173G | Inborn genetic diseases, Charcot-Marie-Tooth disease type 2, not provided, Charcot-Marie-Tooth disease axonal type 2N | Conflicting interpretations of pathogenicity (Jun 15, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70292978
- GRCh38:
- Chr16:70259075
| AARS1 | R633C | Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2 | Uncertain significance (Oct 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70298949
- GRCh38:
- Chr16:70265046
| AARS1 | | Charcot-Marie-Tooth disease type 2, not provided, Inborn genetic diseases, not specified, Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease axonal type 2N, Leukoencephalopathy, hereditary diffuse, with spheroids 2, Trichothiodystrophy 8, nonphotosensitive, Developmental and epileptic encephalopathy, 29
| Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70287883
- GRCh38:
- Chr16:70253980
| AARS1 | K820R | not provided, Inborn genetic diseases, Charcot-Marie-Tooth disease type 2, not specified, Charcot-Marie-Tooth disease axonal type 2N | Likely benign (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70286631
- GRCh38:
- Chr16:70252728
| AARS1 | K967M | Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2, not provided, Leukoencephalopathy, hereditary diffuse, with spheroids 2, Trichothiodystrophy 8, nonphotosensitive, Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease axonal type 2N | Benign/Likely benign (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70304215
- GRCh38:
- Chr16:70270312
| AARS1 | P234S | Inborn genetic diseases, Charcot-Marie-Tooth disease type 2, Leukoencephalopathy, hereditary diffuse, with spheroids 2, Trichothiodystrophy 8, nonphotosensitive, Charcot-Marie-Tooth disease axonal type 2N, Developmental and epileptic encephalopathy, 29, not provided, Charcot-Marie-Tooth disease axonal type 2N | Benign/Likely benign (Sep 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70287290
- GRCh38:
- Chr16:70253387
| AARS1 | | Charcot-Marie-Tooth disease type 2, Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2N
| Benign/Likely benign (Oct 25, 2022) | criteria provided, multiple submitters, no conflicts |